Yatharth Hospitals Q3FY26 Revenue Surges 46% YoY to ₹320.5 Crore, PAT Up 41%
Yatharth Hospitals reported a 46% YoY revenue growth to ₹320.5 crore and a 41% YoY PAT surge to ₹43.1 crore for Q3 FY26. New hospitals contributed 9% to revenue in their first quarter. The company will host an earnings conference call on February 6, 2026.
The significant increase in revenue and profit, along with the successful ramp-up of new facilities, indicates a strong positive impact on the company's financial performance and market position.
The company reported strong year-on-year growth in revenue and PAT, driven by new hospital operations and existing facility performance. Management commentary is optimistic about future growth.
Yatharth Hospital & Trauma Care Services Ltd. announced its financial results for the third quarter and nine months ended December 31, 2025. The company reported a significant year-on-year growth, with revenue increasing by 46% to ₹3,205 million (₹320.5 crore) in Q3 FY26, compared to ₹2,192 million (₹219.2 crore) in Q3 FY25. Profit After Tax (PAT) also saw a substantial rise of 41% YoY, reaching ₹431 million (₹43.1 crore) in Q3 FY26, up from ₹305 million (₹30.5 crore) in the same period last year.
The newly operational hospitals in New Delhi and Faridabad Sector-20 contributed ₹279 million (₹27.9 crore) to the group's revenue, accounting for 9% within their first full quarter. These new facilities derived 100% of their revenue from cash and TPA patients. The Faridabad Sector-20 facility achieved a Monthly Revenue Run Rate (MRR) of ₹7-8 crore within three months of operation, while the New Delhi facility reached an MRR of ₹5 crore within four months.
Existing hospitals demonstrated robust performance with a 33% YoY growth. The Group's Average Revenue Per Bed (ARPOB) witnessed continued momentum at ₹33,744, up 10% YoY, with the Noida Extension recording its highest-ever ARPOB at ₹44,000. EBITDA stood at a record ₹742 million (₹74.2 crore), a 35% increase YoY. Adjusted EBITDA Margin for the group was 29.2% in Q3.
Mr. Yatharth Tyagi, Whole Time Director, expressed satisfaction with the industry-leading performance and rapid scaling of new assets. He highlighted the strategic focus on improving payer mix and expressed confidence in sustaining accelerated growth. The company also announced its earnings conference call scheduled for February 6, 2026, at 1:00 pm IST to discuss the results and answer participant questions.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.